Search results for: meth

This webinar is an introduction to methamphetamines.  It will cover a variety of topics from description of methamphetamines, pharmacology, and reasons for use.  It will also include special populations and evidence based practices.   Goal:  Increase knowledge about methamphetamines and what works for treatment   Objectives: State statistics for methamphetamines locally and nationally Define stimulant drug Describe methamphetamines, withdrawal, and long term effects List at least 5 reasons for use Describe the routes of administration for methamphetamines including oral, snorting, injecting, and booty bumping List special issues for women and methamphetamines List special issues for MSM (Men who have sex with men) Define evidence-based practice and describe 3 evidence-based practices for methamphetamines Part 2 How do you use methamphetamines? Special Issues for women and MSM Treatment:  Evidence-Based Practices   This course is generally three-hours in length, delivered in two segments (1.5 hours each), therefore, participants are required to attend both segments to attain a 'Certificate of Completion'.   This webinar series is provided under New York State Office of Alcoholism and Substance Abuse Services (OASAS) Education and Training. Provider Certification Number (115) Training under a New York State OASAS Provider Certification is acceptable for meeting all or part of the CASAC/CPP/CPS education and training requirements.   Group Registration: If your agency has a group of people (applies to group of people that will watch the webinar together from one access point) during a live broadcast, then the person registering the group must provide us with the names and their respective email addresses within the group to ensure that everyone fills out an evaluation.

This webinar is an introduction to methamphetamines.  It will cover a variety of topics from description of methamphetamines, pharmacology, and reasons for use.  It will also include special populations and evidence based practices.   Goal:  Increase knowledge about methamphetamines and what works for treatment   Objectives: State statistics for methamphetamines locally and nationally Define stimulant drug Describe methamphetamines, withdrawal, and long term effects List at least 5 reasons for use Describe the routes of administration for methamphetamines including oral, snorting, injecting, and booty bumping List special issues for women and methamphetamines List special issues for MSM (Men who have sex with men) Define evidence-based practice and describe 3 evidence-based practices for methamphetamines Part 1 Epidemiology What is it? Pharmacology   This course is generally three-hours in length, delivered in two segments (1.5 hours each), therefore, participants are required to attend both segments to attain a 'Certificate of Completion'.   This webinar series is provided under New York State Office of Alcoholism and Substance Abuse Services (OASAS) Education and Training. Provider Certification Number (115) Training under a New York State OASAS Provider Certification is acceptable for meeting all or part of the CASAC/CPP/CPS education and training requirements.   Group Registration: If your agency has a group of people (applies to group of people that will watch the webinar together from one access point) during a live broadcast, then the person registering the group must provide us with the names and their respective email addresses within the group to ensure that everyone fills out an evaluation.

This Lecture Series presentation will provide a detailed review of local and national emerging drug trends.  Epidemiological data on synthetic drugs, fentanyl, other synthetic opioids, marijuana, methamphetamine, cocaine, mixed opioids/stimulants and vaping (marijuana and nicotine) will be presented.  The presentation will define key terms, describe the major classes of emerging drugs, present available data on the extent of use, and discuss the acute and chronic effects.  The presentation will conclude with a discussion of treatment considerations and health concerns.   A panel discussion will follow this presentation featuring representatives from SAPC’s specialty substance use disorder (SUD) treatment provider network. This portion of the presentation is intended to assist SUD providers in addressing real world concerns with emerging substances of abuse because they are constantly changing.  Additionally, panelists will share their perspectives on the growing use of emerging drugs, as well as their efforts to implement evidence-based treatment options to assist in addressing the ongoing epidemic. Objectives: At the end of this presentation, participants will be able to: 1)    Describe the current information on the availability and patterns of emerging drug tends in the United States. 2)    Identify the key characteristics and acute and chronic effects of synthetic drugs, most notably synthetic opioids (fentanyl), synthetic cannabinoids (spice) and synthetic cathinones (bath salts). 3)    Identify the key characteristics and acute and chronic effects of mixed opioids and stimulants. 4)    Explain strategies for communicating the dangers involved with the use of emerging drugs, including the current vaping lung illness epidemic.

Marcela Smid, MD, MA, M.S,, Assistant Professor of Maternal-Fetal Medicine, University of Utah Health This presentation will address the impact of methamphetamine use during pregnancy on maternal and fetal outcomes. It will also cover current evidence to assist in treatment of women using methamphetamine during pregnancy.     Objectives Overview of evidence-based interventions for pregnant women using methamphetamines.  Discuss perinatal impact of methamphetamine use including maternal, fetal, and infant outcomes.

This course will review crystal meth in the MSM community, describe routes of administration, reasons why MSM use it, treatment options, and barriers to treatment.

This is the 3rd session in the Women and Stimulant Use Project ECHO series. The series will utilize a Project ECHO format to provide case-based learning and consultation for substance use and other health care providers working with women who use stimulants. Using the Zoom videoconferencing platform, providers will be able to connect directly with leading experts in the field to build their capacity to provide evidence-based care. Each 90-minute session will include a brief didactic presentation and an interactive discussion on two de-identified client cases.  Mamas, Munchkins, and Methamphetamines will address the impact of methamphetamine use during pregnancy on maternal and fetal outcomes. And will cover current evidence for treatment of methamphetamine use during pregnancy will be addressed. Objectives Overview of evidence-based interventions for pregnant women using methamphetamines.  Discuss perinatal impact of methamphetamine use including maternal, fetal, and infant outcomes.

There are a number of treatment approaches for the treatment of individuals with methamphetamine use disorders (MUD).This training will describe the most critical components, the challenges, how strategies can be combined, how treatment of individuals with MUD can be individualized, and patient-centered and key elements in monitoring service effectiveness.

Presents the results from an environmental scan reviewing the literature on needs assessment methods and substance use disorder (SUD) needs assessment reports representing diverse interests, including rural and urban areas, researchers, government agencies, and private consultants. Highlights best p

Want to learn more about Methamphetamine? Need resources to share with your colleagues and clients? SAMHSA just released a list of new resources regarding Methamphetamines. Learn about the rise of Meth in the US and specifics on CDC data collected from 2011. The website also contains short term effe

Cocaine and methamphetamine use rates and overdose deaths are rapidly increasing across the United States.  The National Institute of Drug Abuse released a report on methamphetamine in April 2019. Read the report. In addition, the Centers for Disease Control and Prevention released a

This half-day course will introduce participants to crystal methamphetamine use among MSM, which has increased recently in New York City among MSM of color. It will describe crystal meth, routes of administration, reasons why people use it, and some treatment options.

The Mid-America Mountain Plains and the South Southwest Regional Addiction Technology Transfer Center are hosting the Women and Stimulants ECHO Series. This series will utilize a Project ECHO format to provide case-based learning and consultation for substance use and other health care providers working with women who use stimulants, including cocaine and methamphetamines. Using the Zoom videoconferencing platform, providers will be able to connect directly with leading experts in the field to build their capacity to provide evidence-based care. Each 90-minute session will include a brief didactic presentation and an interactive discussion on two de-identified client cases.  Registration is limited to 100 participants per session. Please register for each individual session by clicking on the session titles below. See webpage for detailed descriptions of the sessions and information regarding CEs. To learn more about what a Project ECHO session is like, view this brief video.  Woman and Stimulant Use: Mamas, Munchkins, and Methamphetamines October 30, 2019 from 11:30am- 1:00pm CT Marcela Smid, MD, MA, MS, Assistant Professor of Maternal-Fetal Medicine, University of Utah Health This presentation will address the impact of methamphetamine use during pregnancy on maternal and fetal outcomes. And will cover current evidence for treatment of methamphetamine use during pregnancy will be addressed. Register Here! 

Methamphetamine use is increasing in the wake of the opioid crisis, particularly in the Western United States. This webinar, presented by Sara Glick, PhD, of the University of Washington School of Medicine, describes current trends across our four-state region (WA, OR, ID, AK), including methamphetamine use among people who inject drugs, health consequences like recent HIV outbreaks, non-fatal and fatal overdose, and treatment interest and options. Sara Glick is a Research Assistant Professor at the UW School of Medicine.

This webinar, presented by Richard Rawson, PhD, of UCLA and University of Vermont, provided an overview of the current knowledge on the problem of stimulant (cocaine and methamphetamine) use in the U.S., including a review of the extent and geography of use, the clinical syndromes provided by acute and chronic use, a review of behavioral treatments with evidence of efficacy for the treatment of stimulant use disorders, and an overview of the current status of pharmacotherapy research on treatments for stimulant use disorders. Download slides | Watch recording This is part 1 of a 3-part series on Stimulant Use Disorders sponsored by the Northwest and Great Lakes ATTCs. Find the complete series here.  Webinar category: Stimulants, Treatment - General

Join the Northwest ATTC on July 31st for our latest webinar, "Methamphetamine Use Trends and Consequences in the Northwestern United States," presented by Sara Glick, PhD, Research Assistant Professor at the UW School of Medicine. Methamphetamine use is increasing in the wake of the opioid crisis, p

This webinar will be presented by Sara Glick, PhD, of the University of Washington School of Medicine.  Methamphetamine use is increasing in the wake of the opioid crisis, particularly in the Western United States. This webinar will describe current trends, including methamphetamine use among people who inject drugs, health consequences like recent HIV outbreaks, non-fatal and fatal overdose, and treatment interest and options.

Three-part webinar series offered by the Great Lakes ATTC and the Northwest ATTC. Part 1 of the series provides an overview of stimulant (cocaine and methamphetamine) use in the U.S. Presenter Rick Rawson, PhD will discuss: The extent and geography of stimulant use Clinical syndromes produced by acute and chronic stimulant use Strategies for addressing acute intoxication, withdrawal, and stimulant-induced psychosis Effective behavioral treatments for stimulant use disorders The status of pharmacotherapy research on treatments for stimulant use disorders A discussion of vulnerable populations, including the problem of stimulant use by individuals in medication treatment for opioid use disorder   PowerPoint Presentation  

  By Richard A. Rawson, Ph.D. Research Professor, Vermont Center for Behavior and Health Professor Emeritus, UCLA   Evidence of Re-emergence of Cocaine and Methamphetamine Use The current opioid crisis is arguably the most deadly public health epidemic since the 1918, influenza pandemic i